API reference
Bepotastine besilate
- CAS number
- 190786-44-8
- Molecular formula
- C27H31ClN2O6S
- Molecular weight
- 547.1 g/mol
About this molecule
Bepotastine is a non-sedating, selective antagonist of the histamine 1 (H1) receptor. Bepotastine was approved in Japan for use in the treatment of allergic rhinitis and uriticaria/puritus in July 2000 and January 2002, respectively, and is marketed by Tanabe Seiyaku Co., Ltd. under the brand name Talion. It is available in oral and opthalmic dosage forms in Japan. The opthalmic solution is FDA approved since Sept 8, 2009 and is under the brand name Bepreve.
Source: Toxin and Toxin Target Database (T3DB), via PubChem.
Identifiers
- IUPAC name
- benzenesulfonic acid;4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
- InChIKey
- UDGHXQPQKQPSBB-BOXHHOBZSA-N
- SMILES
- C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O
- PubChem CID
- 164521
Also known as
Bepotastine besilate · Bepotastine besylate · Bepreve · Talion · Bepotastine benzenesulfonate · Bepotastine Benzenesulfonate Salt · Bepotastine Besilate Ophthalmic Solution 1.5% · Betotastine besilate
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.